Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 10Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Prostatic Diseases 1Osteosarcoma 1Neuroblastoma 1Melanoma 1Kidney Neoplasms 1Hepatoblastoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

X-Rays 4Phantoms, Imaging 4Cyclophosphamide 4Specimen Handling 3Melphalan 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3Busulfan 3ulixertinib 2tipifarnib 2tazemetostat 2talazoparib 2selpercatinib 2palbociclib 2ivosidenib 2fludarabine 2cabozantinib 2Vemurafenib 2Topotecan 2Temozolomide 2Sirolimus 2Nuclear Medicine Department, Hospital 2Nivolumab 2LY3023414 2Filgrastim 2Bone Marrow Transplantation 2trioctyl phosphine oxide 1regorafenib 1racotumomab 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Cryotherapy × Genitourinary × Clear all
NCT05302921 2025-01-01

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Children's National Research Institute

Phase 2 Completed
5 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Melanoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡